High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings

(2022) Kenneth Cusi et al.   Endocrine Practice

Impact of non-invasive biomarkers on hepatology practice: Past, present and future

(2022) Quentin M. Anstee et al.   JOURNAL OF HEPATOLOGY

Noninvasive Algorithms for the Case Finding of “At-Risk” Patients with NAFLD

(2022) Laurent Castera et al.   SEMINARS IN LIVER DISEASE

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2022) Melanie J. Davies et al.   DIABETOLOGIA

Non-alcoholic fatty liver disease

(2021) Elizabeth E Powell et al.   LANCET

A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease

(2021) Zobair M. Younossi et al.   Clinical Gastroenterology and Hepatology

Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: A multicenter study

(2021) I. Mikolasevic et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease

(2021) Fasiha Kanwal et al.   GASTROENTEROLOGY

EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update

(2021) Annalisa Berzigotti et al.   JOURNAL OF HEPATOLOGY

Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus

(2021) Vincent Mallet et al.   JOURNAL OF HEPATOLOGY

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

(2021) Tom H Karlsen et al.   LANCET

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

(2021) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies

(2020) Helen Jarvis et al.   PLOS MEDICINE

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

(2020) Beth A. Davison et al.   JOURNAL OF HEPATOLOGY

Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study

(2020) I Mikolasevic et al.   European Journal of Internal Medicine

Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening

(2020) Romina Lomonaco et al.   DIABETES CARE

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis

(2020) Philip N. Newsome et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis

(2019) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Performance of Plasma Biomarkers and Diagnostic Panels for Nonalcoholic Steatohepatitis and Advanced Fibrosis in Patients With Type 2 Diabetes

(2019) Fernando Bril et al.   DIABETES CARE

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Non‐alcoholic Fatty Liver Disease

(2019) Fasiha Kanwal et al.   HEPATOLOGY

4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

(2018) Chris Estes et al.   JOURNAL OF HEPATOLOGY

Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease

(2018) Luis C. Bertot et al.   LIVER INTERNATIONAL

Concomitant screening for liver fibrosis and steatosis in French type 2 diabetic patients using Fibroscan

(2017) Dominique Roulot et al.   LIVER INTERNATIONAL

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD

(2015) Jessica Bazick et al.   DIABETES CARE

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

(2015) Raymond Kwok et al.   GUT

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

(2014) Pierre Bedossa et al.   HEPATOLOGY

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

(2010) Brent A. Neuschwander-Tetri et al.   HEPATOLOGY

Influence of Local Reference Populations on Upper Limits of Normal for Serum Alanine Aminotransferase Levels

(2008) Brent A. Neuschwander-Tetri   ARCHIVES OF INTERNAL MEDICINE